Avedro Crosslinking treatment in our office.The doctors @ Smart Eye Care are now able to offer FDA approved Avedro technology (Avedro.com) in our offices. This is the safest and most effective treatment available for Keratoconus and Post-Lasik ectasia in the United States and the only one approved by the FDA. The treatment is available in our convenient Manhattan Beach office.
Who Can Benefit from Cross-Linking?Keratoconus Patients.
Patients suffering from keratoconus experience a thinning of the cornea causing visual impairments and could lead to corneal transplantation with progression of the condition. Cross-Linking has the ability to stabilize the cornea, repairing its biomechanical integrity and halting progression of keratoconus in the early phases of the condition. The procedure can also be used to treat the vision loss that occurs in patients with a more progressed stage of the keratoconus.
Post-LASIK Ectasia Patients.
Corneal ectasia is a complication that can occur following a LASIK procedure and may result in increasing myopia and astigmatism, loss of visual acuity, steepening of the corneal curvature, and topographic asymmetric steepening of the inferior corneal curvature. Whether a patient develops post-LASIK ectasia weeks or even years after the procedure, Avedro’s Cross-Linking procedure is able to stabilize and strengthen the cornea.
Please visit our Manhattan Beach office or our Brooklyn Heights office for consultation and treatment using Avedro technology.
View Avedro patient brochure.